Regeneron Pharmaceuticals: Truist Securities raises target price to $982 from $780
REGN•Truist Securities raised its target price for Regeneron Pharmaceuticals to $982 from $780.
REGN•REGN•REGN•Truist Securities raised its target price for Regeneron Pharmaceuticals to $982 from $780.
